Novascope Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 35

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $9M

  • Investors
  • 2

Novascope General Information

Description

Developer of a semiconductor-based diagnostic platform intended to deliver rapid and accurate clinical testing through BioIC innovation. The company's vertically integrated BioIC ecosystem features disposable semiconductor biochips and BioFET sensors, enabling clients to perform ultra-sensitive, multiplexed molecular diagnostics at the point of care with laboratory-grade precision.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2F.-9, Number 38, Taiyuan Street
  • Hsinchu County
  • Zhubei City, 302-82
  • Taiwan
+886 03
Primary Industry
Diagnostic Equipment
Other Industries
Application Specific Semiconductors
Biotechnology
Corporate Office
  • 2F.-9, Number 38, Taiyuan Street
  • Hsinchu County
  • Zhubei City, 302-82
  • Taiwan
+886 03

Novascope Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novascope Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 26-Aug-2025 $9M Completed Generating Revenue
2. Early Stage VC (Series A) 11-Apr-2023 Completed Generating Revenue
1. Angel (individual) 31-Dec-2022 $940K $940K Completed Startup
To view Novascope’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Novascope Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novascope Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Orient Europharma Company Corporation Minority
Capital TEN Venture Capital Minority
To view Novascope’s complete investors history, request access »

Novascope FAQs

  • When was Novascope founded?

    Novascope was founded in 2022.

  • Where is Novascope headquartered?

    Novascope is headquartered in Zhubei City, Taiwan.

  • What is the size of Novascope?

    Novascope has 35 total employees.

  • What industry is Novascope in?

    Novascope’s primary industry is Diagnostic Equipment.

  • Is Novascope a private or public company?

    Novascope is a Private company.

  • What is the current valuation of Novascope?

    The current valuation of Novascope is .

  • What is Novascope’s current revenue?

    The current revenue for Novascope is .

  • How much funding has Novascope raised over time?

    Novascope has raised $23.4M.

  • Who are Novascope’s investors?

    Orient Europharma Company and Capital TEN have invested in Novascope.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process